Waldemar Priebe Selected Research

Waldemar Priebe Research Topics

Disease

51	Neoplasms (Cancer) 09/2023 - 12/2002
11	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 10/2007
11	Melanoma (Melanoma, Malignant) 12/2018 - 01/2004
9	Glioma (Gliomas) 01/2022 - 01/2010
7	Breast Neoplasms (Breast Cancer) 12/2018 - 07/2002
4	Neoplasm Metastasis (Metastasis) 12/2018 - 07/2002
4	Brain Neoplasms (Brain Tumor) 12/2018 - 07/2009
4	Carcinoma (Carcinomatosis) 04/2015 - 05/2005
3	Necrosis 04/2015 - 01/2006
3	Carcinogenesis 01/2013 - 12/2008
3	Hypoxia (Hypoxemia) 01/2011 - 12/2002
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2007 - 05/2005
2	Cardiotoxicity 01/2023 - 05/2007
2	COVID-19 10/2021 - 08/2021
2	Infections 10/2021 - 08/2021
2	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 10/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 01/2004
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2017 - 12/2016
2	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 01/2011
2	Leukemia 12/2011 - 04/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2011 - 01/2009
2	Squamous Cell Carcinoma of Head and Neck 07/2011 - 01/2009
2	Hematologic Neoplasms (Hematological Malignancy) 12/2007 - 03/2007
2	Lung Neoplasms (Lung Cancer) 10/2007 - 01/2004
2	Polyploidy 01/2006 - 02/2003
2	Osteosarcoma (Osteogenic Sarcoma) 01/2004 - 12/2002
1	Liver Diseases (Liver Disease) 02/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Disease Progression 01/2022
1	Adenocarcinoma 10/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019

Drug/Important Bio-Agent (IBA)

15	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 07/2002
11	AnthracyclinesIBA 01/2023 - 01/2004
11	WP1066IBA 01/2022 - 12/2007
8	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2006
8	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2012 - 12/2008
7	WP 631IBA 04/2015 - 04/2002
5	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 03/2007
5	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2023 - 05/2005
5	annamycinIBA 01/2023 - 07/2002
5	CytokinesIBA 12/2014 - 05/2005
5	Deoxyglucose (2 Deoxy D glucose)IBA 07/2011 - 12/2002
4	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 12/2006
3	EnzymesIBA 01/2022 - 12/2018
3	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 05/2005
3	degrasynIBA 01/2014 - 04/2007
3	Janus KinasesIBA 01/2014 - 02/2008
3	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 06/2012 - 02/2008
3	WP 1193IBA 05/2012 - 01/2010
3	Phosphotransferases (Kinase)IBA 09/2011 - 12/2007
2	Cytotoxins (Cytolysins)IBA 11/2021 - 12/2014
2	Antiviral Agents (Antivirals)IBA 10/2021 - 08/2021
2	MicroRNAs (MicroRNA)IBA 10/2021 - 08/2021
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2021 - 12/2020
2	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2017 - 04/2007
2	WP760IBA 10/2017 - 10/2007
2	LigandsIBA 05/2017 - 01/2017
2	Insulin (Novolin)FDA Link 01/2017 - 09/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016 - 04/2009
2	epidermal growth factor receptor VIIIIBA 12/2014 - 01/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014 - 12/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2014 - 01/2010
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 09/2012 - 12/2010
2	Janus Kinase 2IBA 05/2012 - 04/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2011 - 01/2004
2	Transcription Factors (Transcription Factor)IBA 12/2007 - 01/2005
2	multidrug resistance-associated protein 1IBA 04/2007 - 04/2007
2	Cisplatin (Platino)FDA LinkGeneric 07/2003 - 01/2003
1	ProdrugsIBA 09/2023
1	EstersIBA 09/2023
1	EsterasesIBA 09/2023
1	CollagenIBA 02/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Chelating AgentsIBA 01/2023
1	IronIBA 01/2023
1	Cytostatic AgentsIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	HexokinaseIBA 01/2022
1	Butyric Acid (Butanoic Acid)IBA 11/2021
1	Histone Deacetylase InhibitorsIBA 11/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2021
1	Mannose (D-Mannose)IBA 04/2021
1	Eph Family Receptors (Eph Receptors)IBA 04/2020
1	AntigensIBA 04/2020
1	Therapeutic UsesIBA 01/2020
1	Contrast MediaIBA 10/2019
1	3,6-di-O-acetyl-2-deoxy-D-glucopyranoseIBA 10/2019
1	Pyruvic Acid (Pyruvate)IBA 10/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2019
1	CarbonIBA 10/2019

Therapy/Procedure

19	Therapeutics 01/2023 - 12/2002
4	Drug Therapy (Chemotherapy) 12/2018 - 01/2010
3	Radiotherapy 01/2022 - 01/2010
3	Immunotherapy 05/2010 - 10/2007
2	Aftercare (After-Treatment) 10/2019 - 07/2002